Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 35 (25) , 6850-6858
Abstract
No abstract availableKeywords
Funding Information
- Fulbright S&T (R01 HL069957)
This publication has 38 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- Injectable preformed scaffolds with shape-memory propertiesProceedings of the National Academy of Sciences, 2012
- Early Cell Loss Associated with Mesenchymal Stem Cell CardiomyoplastyThe Open Tissue Engineering and Regenerative Medicine Journal, 2012
- Cardiac cell therapy: where we've been, where we are, and where we should be headedBritish Medical Bulletin, 2011
- Biomaterial strategies for alleviation of myocardial infarctionJournal of The Royal Society Interface, 2011
- Injectable Materials for the Treatment of Myocardial Infarction and Heart Failure: The Promise of Decellularized MatricesJournal of Cardiovascular Translational Research, 2010
- Magnetic Targeting Enhances Engraftment and Functional Benefit of Iron-Labeled Cardiosphere-Derived Cells in Myocardial InfarctionCirculation Research, 2010
- Noninvasive Quantification and Optimization of Acute Cell Retention by In Vivo Positron Emission Tomography After Intramyocardial Cardiac-Derived Stem Cell DeliveryJACC, 2009
- Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacityProceedings of the National Academy of Sciences, 2009
- Systems approaches to preventing transplanted cell death in cardiac repairJournal of Molecular and Cellular Cardiology, 2008